Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | Tel Aviv | Healthcare | Pharmaceuticals | ILS 69.15B | -19.8x | -0.33 | ILA 6,095 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kamada | Tel Aviv | Healthcare | Pharmaceuticals | ILS 1.23B | 21.1x | 0.17 | ILA 2,139 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rekah | Tel Aviv | Healthcare | Pharmaceuticals | ILS 156.72M | 20.2x | 0.12 | ILA 1,373 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Can Fite Biopharma | Tel Aviv | Healthcare | Pharmaceuticals | ILS 55.19M | -1.5x | -0.04 | ILA 2.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tikun Olam Cannbit | Tel Aviv | Healthcare | Pharmaceuticals | ILS 22.01M | -0.3x | -0.01 | ILA 27.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cannabotech | Tel Aviv | Healthcare | Pharmaceuticals | ILS 2.24M | ILA 123.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |